Fatigue in rheumatoid arthritis and its relation to interleukin-6 serum level

Egyptian Rheumatologist

Volumn 34, Issue 4, 2012, Pages 153-157

  Helal, Abdel Moneim H ^a   Shahine, Enas M ^a   Hassan, Marwa M ^a   Hashad, Doaa I ^a   Moneim, Riham Abdel ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Fatigue; Interleukin 6; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

28 JOINT DISEASE ACTIVITY SCORE; ADULT; ARTICLE; BRISTOL RHEUMATOID ARTHRITIS FATIGUE MULTIDIMENSIONAL QUESTIONNAIRE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

EID: 84880395973     PISSN: 11101164     EISSN: 20902433     Source Type: Journal    
DOI: 10.1016/j.ejr.2012.08.004     Document Type: Article

References (26)

1. Milman N., Karsh J., Booth R.A. Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis. Clin Biochem 2010, 43:1309-1314.
2. Bax M., van Heemst J., Huizinga T.W., Toes R.E. Genetics of rheumatoid arthritis: what have we learned?. Immunogenetics 2011, 63:459-466.
3. Emonts M., Hazes M.J., Houwing-Duistermaat J.J., De Jongh C.E., De Vogel L., Han H.K., et al. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet 2011, 12:36.
4. Srirangan S., Choy E.H. The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskel Dis 2010, 2:247-256.
5. Garnero P., Thompson E., Woodworth T., Smolen J.S. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone. Arthritis Rheum 2010, 62:33-43.
6. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. Rheumatoid arthritis classification criteria an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2010, 9:2569-2581.
7. van Riel P.L.C.M., Scott D.L. EULAR handbook of clinical assessment in rheumatoid arthritis. Alphen Aan Den Rijn 2000, Van Zuiden Communications, The Netherlands.
8. Singh H., Kumar H., Handa R., Talapatra P., Ray S., Gupta V. Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis patients: an Indian experience. Arthritis 2011, 2011:1-5.
9. Nicklin J., Cramp F., Kirwan J., Greenwood R., Urban M., Hewlett S. Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire, Visual Analog Scales, and Numerical Rating Scales. Arthritis Care Res 2010, 62:1559-1568.
10. Dacie J.V., Lewis S.M. Practical haematology 2006, Churchill Livingstone, Edinburgh-London. 10th ed.
11. John B.H. Clinical diagnosis and management by laboratory methods 2001, Philadelphia, Saunders. 20th ed.
12. Kricka L.J. Principles of immunochemical techniques. Teitz textbook of clinical chemistry and molecular diagnostics 2006, vol. 1:219. Elsevier Saunders, Philadelphia. 4th ed.
13. Hewlett S., Chalder T., Choy E., Cramp F., Davis B., Dures E., et al. Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatol 2011, 50:1004-1006.
14. Dayer E., Dayer J.M., Roux-Lombard P. Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases. Nat Clin Pract Rheumatol 2007, 3:512-520.
15. Smolen J.S., Beaulieu A., Rubbert-Roth A., Ramous-Remus C., Rovensky J., Alecock E., et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomized trial. Lancet 2008, 371:987-997.
16. Wirnsberger R.M., De Vries J., Jansen T.L.T.A., Van Heck G.L., Wouters E.F.M., Drent M. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med 1999, 54:86-95.
17. Bergman M.J., Shahouri S.H., Shaver T.S., Anderson J.D., Weidensaul D.N., Busch R.E., et al. Is fatigue an inflammatory variable in Rheumatoid Arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J Rheumatol 2009, 36:2788-2794.
18. Pollard L.C., Choy E.H., Gonzalez J., Khoshaba B., Scott D.L. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatol 2006, 45:885-889.
19. Repping-Wuts H., Fransen J., Van Achterberg T., Bleijenberg G., Van Riel P. Persistent severe fatigue in patients with rheumatoid arthritis. J Clin Nurs 2007, 16:377-383.
20. Turan Y., Kocaaĝa Z., Koçyiĝit H., Gürgan A., Bayram K.B., Ipek S. Correlation of fatigue with clinical parameters and quality of life in rheumatoid arthritis. Turk J Rheumatol 2010, 25:63-67.
21. Pinals R., Masi A.T., Larsen R.A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981, 24:1308-1315.
22. Nikolaus S., Bode C., Taal E., Van De Laar M. New insights into the experience of fatigue among patients with rheumatoid arthritis: a qualitative study. Ann Rheum Dis 2010, 69:895-897.
23. Huyser B.A., Parker J.C., Thoreson R., Smarr K.L., Johnson J.C., Hoffman R. Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum 1998, 41:2230-2237.
24. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254.
25. Chung S.J., Kwon Y.J., Park M.C., Park Y.B., Lee S.K. The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients. Yonsei Med J 2011, 52:113-120.
26. Madhok R., Crilly A., Watson J., CapelI H.A. Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis 1993, 52:232-234.